Skip to main content
SpringerLink
Log in

Immunopathology of acetylcholine receptors in myasthenia gravis

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Summary

It is now clear that the muscular weakness and fatigability seen in MG result from an antibody-mediated immune response to AChR. The mechanisms by which antibodies impair transmission are moderately well understood and detection of antibodies in patient's sera is a reliable diagnostic test for the disease. The spectrum of antibody specificities produced in MG is also beginning to be understood, largely through the use of antibodies produced in the experimental model EAMG. Treatment for MG continues to rely heavily on the symptomatic relief afforded by acetylcholinesterase inhibitors. However, the recent recognition of the autoimmune nature of MG has led to increased emphasis on immunosuppression and antibody removal with some beneficial effects. Despite all that has been learned, the level of ignorance has just been pushed back one step -from the neuromuscular junction to the immune system. What initiates the immune response to AChR in MG and how to specifically suppress this aberrant response remain completely unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aarli JA, Heimann P, Matre R (1979) Lymphocyte subpopulations in thymus and blood from patients with myasthenia gravis. J Neurol Neurosurg Psychiatry 42: 29

    PubMed  Google Scholar 

  2. Abramsky O, Tarrab-Hazdai R, Aharonov A (1976) Immunosuppression of experimental autoimmune myasthenia gravis by hydrocortisone and azathioprine. J Immunol 117: 225

    PubMed  Google Scholar 

  3. Abramsky O, Brenner T (1979)α-Fetoprotein inhibits antibody binding to acetylcholine receptor. Significance for myasthenia gravis and other autoimmune diseases. Isr J Med Sci 15: 943

    PubMed  Google Scholar 

  4. Anholt R, Lindstrom J, Montal M (1980) Functional equivalence of monomeric and dimeric forms of purified acetylcholine receptors fromTorpedo californica in reconstituted lipid vesicles. Eur J Biochem 109: 481

    PubMed  Google Scholar 

  5. Appel SH, Almon RR, Levy N (1975) Acetylcholine receptor antibodies in myasthenia gravis. N Engl J Med 293: 760

    PubMed  Google Scholar 

  6. Appel SH, Anwyl R, McAdams MW (1977) Accelerated degradation of acetylcholine receptor from cultured rat myotubes with myasthenia gravis sera and globulins. Proc Natl Acad Sci USA 74: 2130

    PubMed  Google Scholar 

  7. Arts WF, Oosterhuis HF (1975) Effect of prednisolone on neuromuscular blocking in mice in vivo. Neurology (NY) 25: 1088

    Google Scholar 

  8. Ashizawa T, Elias SB, Appel SH (1982) Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes. Ann Neurol 11: 22

    PubMed  Google Scholar 

  9. Bach JF (1976) The pharmacological and immunological basis for the use of immunosuppressive drugs. Drugs 11: 1

    PubMed  Google Scholar 

  10. Barkas T, Simpson JA (1982) Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis. Clin Exp Immunol 47: 119

    PubMed  Google Scholar 

  11. Behan PO, Shakir RA, Simpson JA (1979) Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet 2: 438

    PubMed  Google Scholar 

  12. Bender AN, Ringel SP, Engel WK (1976) Immunoperoxidase localization of alpha bungarotoxin: a new approach to myasthenia gravis. Ann NY Acad Sci 274: 20

    PubMed  Google Scholar 

  13. Bergstrom K, Franksson C, Matell G (1973) The effect of thoracic duct drainage in myasthenia gravis. Eur Neurol 9: 157

    PubMed  Google Scholar 

  14. Berrih S, Gaud C, Bach M-A (1981) Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. Clin Exp Immunol 45: 1

    PubMed  Google Scholar 

  15. Birnbaum G, Tsairis P (1976) Suppressor lymphocytes in myasthenia gravis and effect of adult thymectomy. Ann NY Acad Sci 274: 527

    PubMed  Google Scholar 

  16. Blalock A (1941) Tumors of the thymic region and myasthenia gravis. Am J Surg 57: 149

    Google Scholar 

  17. Brunner NG, Namba T, Grob D (1972) Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy. Neurology (NY) 22: 603

    Google Scholar 

  18. Buckingham JM, Howard FM Jr, Bernatz PE (1976) The value of thymectomy in myasthenia gravis: a computer-assisted matched study. Ann Surg 184: 453

    PubMed  Google Scholar 

  19. Burres SA, Crayton JW, Gomez CM (1981) Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects. Ann Neurol 9: 563

    PubMed  Google Scholar 

  20. Campbell WW Jr, Leshner RT, Swift TR (1980) Plasma exchange in myasthenia gravis: electrophysiological studies. Ann Neurol 8: 584

    PubMed  Google Scholar 

  21. Carter B, Harrison R, Lunt GG (1980) Anti-acetylcholine receptor antibody titers in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy. J Neurol Neurosurg Psychiatry 43: 397

    PubMed  Google Scholar 

  22. Castleman B (1966) The pathology of the thymus gland in myasthenia gravis. Ann NY Acad Sci 135: 496

    PubMed  Google Scholar 

  23. Cautaud J, Benedetti EL, Cohen JB (1973) Presence of a lattice structure in membrane fragments rich in nicotinic receptor protein from the electric organ ofTorpedo marmorata. FEBS Lett 33: 109

    PubMed  Google Scholar 

  24. Chang CC, Chen TF, Chuang S-T (1973) Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragm. J Physiol (Lond) 230: 613

    Google Scholar 

  25. Chang CC, Chuang S-T, Huang MC (1975) Effects of chronic treatment with various neuromuscular blocking agents on the number and distribution of acetylcholine receptors in the rat diaphragm. J Physiol (Lond) 250: 161

    Google Scholar 

  26. Changeux JP (1981) The acetylcholine receptor: an “allosteric” membrane protein. Harvey Lect 75: 85

    Google Scholar 

  27. Christadoss P, Lennon VA, David C (1979) Genetic control of experimental autoimmune myasthenia gravis in mice. I. Lymphocyte proliferative response to acetylcholine receptor is under H-2-linked Ir gene control. J Immunol 123: 2540

    PubMed  Google Scholar 

  28. Christadoss P, Lennon VA, Krco CJ (1981) Genetic control of autoimmunity to acetylcholine receptors: role of Ia molecules. Ann NY Acad Sci 377: 258

    PubMed  Google Scholar 

  29. Christadoss P, Lennon VA, Krco CJ (1982) Genetic control of experimental autoimmune myathenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors. J Immunol 128: 1141

    PubMed  Google Scholar 

  30. Clarke C, Vincent A, Newsom-Davis J (1979) Studies of anti-acetylcholine receptor antibody synthesis by peripheral blood lymphocytes in myasthenia gravis. Clin Sci 56: lp

  31. Conti-Tronconi BM, Morgutti M, Sghirlanzoni A (1979) Cellular immune response against acetylcholine receptor in myasthenia gravis: I. Relevance to clinical course and pathogenesis. Neurology (NY) 29: 496

    Google Scholar 

  32. Conti-Tronconi BM, Tzartos S, Lindstrom J (1981) Monoclonal antibodies as probes of acetylcholine receptor structure. 2. Binding to native receptor. Biochemistry 20: 2181

    PubMed  Google Scholar 

  33. Cull-Candy SG, Miledi R, Trautmann A (1979) End-plate currents and acetylcholine noise at normal and myasthenic human end-plates. J Physiol (Lond) 287: 247

    Google Scholar 

  34. Cull-Candy SG, Miledi R, Uchitel OD (1980) Diffusion of acetylcholine in the synaptic cleft of normal and myasthenia gravis human endplates. Nature 286: 500

    PubMed  Google Scholar 

  35. Dan PC, Lindstrom JM, Cassel CK (1977) Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 297: 1134

    PubMed  Google Scholar 

  36. Dau P (1981) Response to plasmapheresis and immunosuppressive therapy in sixty myasthenia gravis patients. Ann NY Acad Sci 377: 700

    PubMed  Google Scholar 

  37. Dawson DM (1982) Progressive multifocal leukoencephalopathy in myasthenia gravis. Ann Neurol 11: 218–219

    PubMed  Google Scholar 

  38. DeBaets MH, Einarson B, Lindstrom JM (1982) Lymphocyte activation in experimental autoimmune myasthenia gravis. J Immunol 128: 2228

    PubMed  Google Scholar 

  39. Desouki A, Eldefrawi AT, Eldefrawi ME (1981) A new mechanism revealed for the action of antibodies on acetylcholine receptor function. Exp Neurol 73: 440

    PubMed  Google Scholar 

  40. Dionne VE, Steinbach JH, Stevens CF (1978) An analysis of the dose-response relationship at voltage-clamped frog neuromuscular junctions. J Physiol (Lond) 281: 421

    Google Scholar 

  41. Drachman DB, Adams RN, Stainley EF (1980) Mechanisms of acetylcholine receptor loss in myasthenia gravis. J Neurol Neurosurg Psychiatry 43: 601

    PubMed  Google Scholar 

  42. Dreyer F, Peper K, Akert K (1973) Ultrastructure of the “active zone” in the frog neuromuscular junction. Brain Res 62: 373

    PubMed  Google Scholar 

  43. Einarson B, Gullick W, Conti-Tronconi B (to be published) Subunit composition of bovine acetylcholine receptor. Biochemistry 21: 5295

  44. Engel AG, Lambert EH, Santa T (1973) Study of long-term anticholinesterease therapy. Effects on neuromuscular transmission and on motor end-plate fine structure. Neurology (NY) 23: 1273

    Google Scholar 

  45. Engel AG, Tsujihata M, Lambert EH (1976) Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. J Neuropathol Exp Neurol 35: 569

    PubMed  Google Scholar 

  46. Engel AG, Tsujihata M, Lindstrom JM (1976) The motor endplate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Ann NY Sci 274: 60

    Google Scholar 

  47. Engel AG, Lindstrom JM, Lambert EH (1977) Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (NY) 27: 307

    Google Scholar 

  48. Engel AG, Lambert EH, Howard FM Jr (1977) Immune complexes (IgG and C3) at the motor endplate in myasthenia gravis. Ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 52: 267

    PubMed  Google Scholar 

  49. Engel AG, Sakakibara H, Sahashi K (1979) Passively transferred experimental autoimmune myasthenia gravis: sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor. Neurology (NY) 29: 179

    Google Scholar 

  50. Engel AG (1979) Myasthenia gravis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, Vol. 41. North Holland, Amsterdam, P 95

    Google Scholar 

  51. Engel WK, Trotter JL, McFarlin DE (1977) Thymic epithelial cell contains acetylcholine receptor. Lancet 1: 1310

    PubMed  Google Scholar 

  52. Engel WK, Lichter AS, Dalakas MC (1981) Splenic and total-body irradiation treatment of myasthenia gravis. Ann NY Acad Sci 377: 744

    PubMed  Google Scholar 

  53. Fambrough DM (1979) Control of acetylcholine receptors in skeletal muscle. Physiol Rev 59: 165

    PubMed  Google Scholar 

  54. Feltkamp TEW, Van Den Berg-Loonen PM, Nijenhuis LE (1974) Myasthenia gravis, autoantibodies, and HL-A antigens. Br Med J 1: 131

    PubMed  Google Scholar 

  55. Fritze D, Herrmann C Jr, Naeim F (1974) HL-A antigens in myasthenia gravis. Lancet 1: 240

    PubMed  Google Scholar 

  56. Froehner SC, Reiness CG, Hall ZW (1977) Subunit structure of the acetylcholine receptor from denervated rat skeletal muscle. J Biol Chem 252: 8589

    PubMed  Google Scholar 

  57. Fumagalli G, Engel AG, Lindstrom J (1982) Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis. J Neuropathol Exp Neurol (in press)

  58. Gardner JM, Fambrough DM (1979) Acetylcholine receptor degradation measured by density labeling: effects of cholinergic ligands and evidence against recycling. Cell 16: 661

    PubMed  Google Scholar 

  59. Goldstein G, Whittingham S (1966) Experimental autoimmune thymitis. An animal model of human myasthenia gravis. Lancet 2: 315

    PubMed  Google Scholar 

  60. Grob D, Harvey AM (1952) Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration. Johns Hopkins Med J 91: 124

    Google Scholar 

  61. Grob D, Namba T (1966) Corticotropin in generalized myasthenia gravis: effect of short, intensive courses. JAMA 198: 703

    PubMed  Google Scholar 

  62. Grob D, Brunner NG, Namba T (1981) The natural course of myasthenia gravis and effect of therapeutic measures. Ann NY Acad Sci 377: 652

    PubMed  Google Scholar 

  63. Gutmann L, Seybold ME (1980) Acetylcholine receptor antibodies in absence of neonatal myasthenia gravis. Arch Neurol 37: 738

    Google Scholar 

  64. Hall ZW (1973) Multiple forms of acetylcholinesterase and their distribution in endplate and nonendplate regions of rat diaphragm muscle. J Neurobiol 4: 343

    PubMed  Google Scholar 

  65. Harfast B, Huddlestone JR, Braheny S (1981) Myasthenia gravis: in vitro immunoglobulm production with pokeweed mitogen challenge and Band T-lymphocyte competence. Clin Immunol Immunopathol 20: 336

    PubMed  Google Scholar 

  66. Hartzell HC, Kuffler SW, Yoshikami D (1975) Postsynaptic potentiation: interaction between quanta of acetylcholine at the skeletal neuromuscular synapse. J Physiol (Lond) 251: 427

    Google Scholar 

  67. Hawkey CJ, Newsom-Davis J, Vincent A (1981) Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy. J Neurol Neurosurg Psychiatry 44: 469

    PubMed  Google Scholar 

  68. Heinemann S, Merlie J, Lindstrom J (1978) Modulation of acetylcholine receptor in rat diaphragm by anti-receptor sera. Nature 274: 65

    PubMed  Google Scholar 

  69. Hertel G, Mertens HG, Reuther P (1979) The treatment of myasthenia gravis with azathioprine. In: Dan PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 315

    Google Scholar 

  70. Heuser JE, Reese TS (1973) Evidence for recycling of synaptic vesicle membrane during transmitter release at the frog neuromuscular junction. J Cell Biol 57: 315

    PubMed  Google Scholar 

  71. Heuser JE, Salpeter SR (1979) Organization of acetylcholine receptors in quick-frozen, deep-etched, and rotary-replicatedTorpedo postsynaptic membrane. J Cell Biol 82: 150

    PubMed  Google Scholar 

  72. Howard FM Jr, Duane DD, Lambert EH (1976) Alternate-day prednisone: preliminary report of a double-blind controlled study. Ann NY Acad Sci 274: 596

    PubMed  Google Scholar 

  73. Hudson CS, Rash JE, Tiedt TN (1978) Neostigmine-induced alterations at the mammalian neuromuscular junction. II. Ultrastructure. J Pharmacol Exp Ther 205: 340

    PubMed  Google Scholar 

  74. Kamo I, Furukawa S, Tada A (1982) Monoclonal antibody to acetylcholine receptor: cell line established from thymus of patient with myasthenia gravis. Science 215: 995

    PubMed  Google Scholar 

  75. Kao I, Drachman DB (1977) Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 195: 74

    PubMed  Google Scholar 

  76. Kao I, Drachman DB (1977) Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science 196: 527

    PubMed  Google Scholar 

  77. Karlin A (1980) Molecular properties of nicotinic acetylcholine receptors. In: Cotman CW, Poste G, Nicolson GL (eds) The cell surface and neuronal function. Elsevier/North Holland, New York, p 191

    Google Scholar 

  78. Katz B, Miledi R (1972) The statistical nature of the acetylcholine potential and its molecular components. J Physiol (Lond) 224: 665

    Google Scholar 

  79. Katz B, Miledi R (1973) The binding of acetylcholine to receptors and its removal from the synaptic cleft. J Physiol (Lond) 231: 549

    Google Scholar 

  80. Katz B, Miledi R (1976) The analysis of end-plate noise-a new approach to the study of acetylcholine/receptor interaction. In: Thesleff S (ed) Motor innervation of muscle. Academic Press, New York, p31

    Google Scholar 

  81. Keesey J, Lindstrom J, Cokely H (1977) Anti-acetylcholine receptor in neonatal myasthenia gravis. N Engl J Med 296: 55

    Google Scholar 

  82. Keesey J, Buffkin D, Kebo D (1981) Plasma exchange alone as therapy for myasthenia gravis. Ann NY Acad Sci 377: 729

    PubMed  Google Scholar 

  83. Keesey J, Naiem F, Lindstrom J (1982) Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis. Arch Neurol 39: 73

    PubMed  Google Scholar 

  84. Kelley RE, Keesey JC, Goymerac V (1981) Immunoregulation of total IgC synthesis in myasthenia gravis. Ann NY Acad Sci 377: 403

    PubMed  Google Scholar 

  85. Kelly JJ Jr, Lambert EH, Lennon VA (1978) Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis. Ann Neurol 4: 67

    PubMed  Google Scholar 

  86. Keyes G (1954) Surgery of the thymus gland. Second (and third) thoughts. Lancet 1: 1197

    Google Scholar 

  87. Kim YI, Goldner MM, Sanders DB (1979) Short-term effects of prednisolone on neuromuscular transmission in normal rats and in those with experimental autoimmune myasthenia gravis. J Neurol Sci 41: 223

    PubMed  Google Scholar 

  88. Kistler J, Sterod RM, Klymkowsky MW (1982) Structure and function of an acetylcholine receptor. Biophys J 37: 371

    PubMed  Google Scholar 

  89. Koethe SM, Cook A, McQuillen DP (1981) Clinical and immunologic correlations in myasthenia gravis: measurement of Con A stimulated suppressor cell activity. Ann NY Acad Sci 377: 447

    PubMed  Google Scholar 

  90. Kornfeld P, Genkins G, Papatestas AE (1978) Steroid therapy in myasthenia gravis associated with thymoma. Mt Sinai J Med (NY) 45: 106

    Google Scholar 

  91. Kornfeld P, Ambinder EP, Mittag T (1981) Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol 38: 478

    PubMed  Google Scholar 

  92. Krenz W-D, Tashiro T, Wachtler K (1980) Aspects of the chemical embryology of the electromotor system ofTorpedo marmorata with special reference to synaptogenesis. Neuroscience 5: 617

    PubMed  Google Scholar 

  93. Kuffler SE, Yoshikami D (1975) The number of transmitter molecules in a quantum: an estimate from iontophoretic application acetylcholine at the neuromuscular synapse. J Physiol (Lond) 251: 465

    Google Scholar 

  94. Lambert EH, Elmquist D (1971) Quantal components of end-plate potentials in the myasthenic syndrome. Ann NY Acad Sci 183: 183

    PubMed  Google Scholar 

  95. Lambert EH, Lindstrom JM, Lennon VA (1976) End-plate potentials in experimental autoimmune myasthenia gravis in rats. Ann NY Acad Sci 274: 300

    PubMed  Google Scholar 

  96. Lefvert AK, Matell G (1977) Antibodies against human cholinergic receptor proteins in patients with myasthenia gravis: studies during immunosuppressive treatment. Acta Med Scand 201: 181

    PubMed  Google Scholar 

  97. Lennon VA, Lindstrom JM, Seybold ME (1975) Experimental autoimmune myasthenia: a model of myasthenia gravis in rats and guinea pigs. J Exp Med 141: 1365

    PubMed  Google Scholar 

  98. Lennon VA, Seybold ME, Lindstrom JM (1978) Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med 147: 973

    PubMed  Google Scholar 

  99. Lennon VA, Lambert EH (1980) Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285: 238

    PubMed  Google Scholar 

  100. Lennon VA, Lambert EH (1981) Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Ann NY Acad Sci 377: 77

    PubMed  Google Scholar 

  101. Levine GD (1979) Pathology of the thymus in myasthenia gravis: current concepts. In: Dan PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 113

    Google Scholar 

  102. Libby P, Bursztajn S, Goldberg AL (1980) Degradation of the acetylcholine receptor in cultured muscle cells: selective inhibitors and the fate of undegraded receptors. Cell 19: 481

    PubMed  Google Scholar 

  103. Linden DC, Fambrough DM (1979) Biosynthesis and degradation of acetylcholine receptors in rat skeletal muscles. Effects of electrical stimulation. Neuroscience 4: 527

    PubMed  Google Scholar 

  104. Lindstrom JM, Einarson BL, Lennon VA (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis. J Exp Med 144: 726

    PubMed  Google Scholar 

  105. Lindstrom JM, Lennon VA, Seybold ME (1976) Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann NY Acad Sci 274: 254

    PubMed  Google Scholar 

  106. Lindstrom JM, Seybold ME, Lennon VA (1976) Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology (NY) 26: 1054

    Google Scholar 

  107. Lindstrom J, Campbell M, Nave B (1978) Specificities of antibodies to acetylcholine receptors. Muscle Nerve 1: 140

    PubMed  Google Scholar 

  108. Lindstrom JM, Einarson B, Merlie J (1978) Immunization of rats with polypeptide chains from torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc Natl Acad Sci USA 75: 769

    PubMed  Google Scholar 

  109. Lindstrom JM, Lambert EH (1978) Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology (NY) 28: 130

    Google Scholar 

  110. Lindstrom JM, Merlie J, Yogeeswaran G (1979) Biochemical properties of acetylcholine receptor subunits fromTorpedo californica. Biochemistry 18: 4465

    PubMed  Google Scholar 

  111. Lindstrom JM, Anholt R, Einarson B (1980) Purification of acetylcholine receptors, reconstitution into lipid vesicles and study of agonist-induced cation channel regulation. J Biol Chem 255: 8340

    PubMed  Google Scholar 

  112. Lindstrom JM, Cooper J, Tzartos S (1980) Acetylcholine receptors fromTorpedo andElectrophorus have similar subunit structures. Biochemistry 19: 1454

    PubMed  Google Scholar 

  113. Lindstrom JM, Tzartos S, Gullick W (1981) Structure and function of the acetylcholine receptor molecule studied using monoclonal antibodies. Ann NY Acad Sci 377: 1

    Google Scholar 

  114. Lisak RP, Schotland DL (1978) Plasmapheresis in the treatment of myasthenia gravis. Trans Am Neurol Assoc 103: 292

    PubMed  Google Scholar 

  115. Lisak RP, Zweiman B, Phillips SM (1978) Thymic and peripheral blood T- and B-cell levels in myasthenia gravis. Neurology (NY) 28: 1298

    Google Scholar 

  116. Lisak RP, Abramsky O, Schotland DL (1979) Plasmapheresis in the treatment of myasthenia gravis: preliminary studies in 21 patients. In: Dan PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 209

    Google Scholar 

  117. Lisak RP, Barachi RE (1982) Myasthenia gravis. WB Saunders, Philadelphia

    Google Scholar 

  118. Lisak RP, Zweiman B, Skolnick P (1982) Thymic lymphocyte sub populations in myasthenia gravis. Neurology (NY) 32: A124

    Google Scholar 

  119. Matell G (1981) Discussion on effect of azathioprine. Ann NY Acad Sci 377: 699

    Google Scholar 

  120. McMahon UJ, Sanes JR, Marshall LM (1978) Cholinesterase is associated with the basal lamina at the neuromuscular junction. Nature 271: 172

    PubMed  Google Scholar 

  121. Mellinger J, Belbenoit P, Ravaille M (1978) Electric organ development inTorpedo marmorata, chondrichthyes. Dev Biol 67: 167

    PubMed  Google Scholar 

  122. Merlie JP, Heinemann S, Lindstrom JM (1979) Acetylcholine receptor degradation in adult rat diaphragms in organ culture and the effect of anti-acetylcholine receptor antibodies. J Biol Chem 254: 6320

    PubMed  Google Scholar 

  123. Merlie JP, Heinemann S, Einarson B (1979) Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis. J Biol Chem 254: 6328

    PubMed  Google Scholar 

  124. Mertens HG, Hertel G, Reuther P (1981) Effect of immunosuppressive drugs (Azathioprine). Ann NY Acad Sci 377: 691

    PubMed  Google Scholar 

  125. Millikan CH, Eaton LH (1951) Clinical evaluation of ACTH and cortisone in myasthnia gravis. Neurology (NY) 1: 145

    Google Scholar 

  126. Mischak RP, Dau PC (1981) Lymphocyte binding antibodies and suppressor cell activity in myasthenia gravis. Ann NY Acad Sci 377: 436

    PubMed  Google Scholar 

  127. Morgutti M, Conti-Tronconi BM, Sghirlanzoni A (1979) Cellular immune response to acetylcholine receptor in myasthenia gravis: II. Thymectomy and corticosteroids. Neurology (NY) 29: 734

    Google Scholar 

  128. Namba T, Brown SB, Grob D (1970) Neonatal myasthenia gravis: report of two cases and review of the literature. Pediatrics 45: 488

    PubMed  Google Scholar 

  129. Nelles MJ, Gill-Pazaras LA, Nisonoff A (1981) Monoclonal anti-idiotypic antibodies reactive with a highly conserved determinant on A/J serum anti-p-azophenylarsonate antibodies. J Exp Med 154: 1752

    PubMed  Google Scholar 

  130. Neubig RR, Cohen JB (1979) Equilibrium binding of [3H] tubocurarine and [3H] acetylcholine byTorpedo postsynaptic membranes: stoichiometry and ligand interactions. Biochemistry 18: 5464

    PubMed  Google Scholar 

  131. Newsom-Davis J, Pinching AJ, Vincent A (1978) Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology (NY) 28: 266

    Google Scholar 

  132. Newsom-Davis J, Ward CD, Wilson SG (1979) Plasmapheresis: short- and long-term benefits? In: Dan PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 199

    Google Scholar 

  133. Newsom-Davis J (1979) Anti-acetylcholine receptor antibody in myasthenia gravis. In: Rose FC (ed) Clinical neuroimmunology. Blackwell, Oxford Scientific Publications, p 128

  134. Newsom-Davis J, Willcox N, Calder L (1981) Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes. N Engl J Med 305: 1313

    PubMed  Google Scholar 

  135. Nielsen VK, Paulson OB, Rosenkvist J (1982) Rapid improvement of myasthenia gravis after plasma exchange. Ann Neurol 11: 160

    PubMed  Google Scholar 

  136. Noble MD, Brown TH, Peacock JH (1978) Regulation of acetylcholine receptor levels by a cholinergic agonist in mouse muscle cell cultures. Proc Natl Acad Sci USA 75: 3488

    PubMed  Google Scholar 

  137. Noguchi SA, Drachman DB, Adams RN (1980) Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis. Ann Neurol 8: 32

    PubMed  Google Scholar 

  138. Noronha ABC, Antel JP, Roos RP (1981) Circulating immune complexes in neurologic disease. Neurology (NY) 31: 1402

    Google Scholar 

  139. Olarte MR, Schoenfeldt RS, Penn AS (1981) Effect of plasmapheresis in myasthenia gravis 1978–1980. Ann NY Acad Sci 377: 725

    PubMed  Google Scholar 

  140. Osserman KE, Genkins G (1966) Studies in myasthenia gravis. Short-term massive corticotropin therapy. JAMA 198: 699

    PubMed  Google Scholar 

  141. Osserman KE, Tsairis P, Weiner LB (1967) Myasthenia gravis and thyroid disease: clinical and immunologic correlation. Mt Sinai J Med (NY) 34: 469

    Google Scholar 

  142. Patrick J, Lindstrom J (1973) Autoimmune response to acetylcholine receptor. Science 180: 871

    PubMed  Google Scholar 

  143. Patten BM (1981) Discussion on plasma exchange. Ann NY Acad Sci 377: 742

    Google Scholar 

  144. Perez MC, Buot WL, Mercado-Danguilan C (1981) Stable remissions in myasthenia gravis. Neurology (NY) 31: 32

    Google Scholar 

  145. Perlo VP, Arnason BGW, Castleman B (1975) The thymus gland in elderly patients with myasthenia gravis. Neurology (NY) 25: 294

    Google Scholar 

  146. Pestronk A, Drachman DB (1981) Therapeutic strategies in experimental autoimmune myasthenia gravis. Ann NY Acad Sci 377: 278

    PubMed  Google Scholar 

  147. Pinching AJ, Peters DK, Newsom-Davis J (1976) Remission of myasthenia gravis following plasma exchange. Lancet 2: 1373

    PubMed  Google Scholar 

  148. Priofsky B (1981) The effect of anti-thymocyte antiserum in progressive myasthenia gravis. Ann NY Acad Sci 377: 779

    PubMed  Google Scholar 

  149. Raftery MA, Hunkapiller MW, Strader CD (1980) Acetylcholine receptor: complex of homologous subunits. Science 208: 1454

    PubMed  Google Scholar 

  150. Rahamimoff R (1976) The role of calcium in transmitter release at the neuromucular junction. In: Thesleff S (ed) Motor innervation of muscle. Academic Press, New York, p 117

    Google Scholar 

  151. Reuther P, Fulpius BW, Mertens HG (1979) Anti-acetylcholine receptor antibody under long-term azathioprine treatment in myasthenia gravis. In: Dan PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 329

    Google Scholar 

  152. Reynolds J, Karlin A (1978) Molecular weight in detergent solution of acetylcholine receptor fromTorpedo californica. Biochemistry 17: 2035

    PubMed  Google Scholar 

  153. Richman DP, Antel JP, Patrick JW (1979) Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site. Neurology (NY) 29: 291

    Google Scholar 

  154. Rodriguez M, Gomez MR, Howard FM Jr (1982) Myasthenia gravis in children: long-term follow-up. Ann Neurol (in press)

  155. Rosenberry TL (1975) Acetylcholinesterase. Adv Enzymol 43: 103

    PubMed  Google Scholar 

  156. Rowland LP, Aranow H, Hoefer PFA (1957) Myasthenia gravis appearing after the removal of thymoma. Neurology (NY) 7: 582

    Google Scholar 

  157. Rowland LP (1980) Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psychiatry 43: 644

    PubMed  Google Scholar 

  158. Sachs JA (1979) The relevance of HLA antigens in some neurological diseases. In: Rose FC (ed) Clinical neuroimmunology. Blackwell Scientific Publications, Oxford, p 42

    Google Scholar 

  159. Sahashi K, Engel AG Lindstrom JM (1978) Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis. J Neuropathol Exp Neurol 37: 212

    PubMed  Google Scholar 

  160. Sahashi K, Engel AG, Lambert EH (1980) Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol 39: 160

    PubMed  Google Scholar 

  161. Sanders DB, Johns TR, Eldefrawi MZ (1977) Experimental autoimmune myasthenia gravis in rats. Modification by thymectomy and prednisolone. Arch Neurol 34: 75

    PubMed  Google Scholar 

  162. Sanders DB, Howard JR Jr, Johns TR (1979) High-dose daily prednisone in the treatment of myasthenia gravis. In: Dan PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 289

    Google Scholar 

  163. Scadding GK, Thomas HC, Havard CWH (1977) Myasthenia gravis: acetylcholine-receptor antibody titres after thymectomy. Br Med J 1: 1512

    PubMed  Google Scholar 

  164. Scadding GK, Webster ADB, Ross M (1979) Humoral immunity before and after thymectomy in myasthenia gravis. Neurology (NY) 29: 502

    Google Scholar 

  165. Scadding GK, Vincent A, Newsom-Davis J (1981) Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology. Neurology (NY) 31: 935

    Google Scholar 

  166. Seybold ME, Howard FM Jr, Duane DD (1971) Thymectomy in juvenile myasthenia gravis. Arch Neurol 25: 385

    PubMed  Google Scholar 

  167. Seybold ME, Drachman DB (1974) Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med 290: 81

    PubMed  Google Scholar 

  168. Seybold ME, Lambert EH, Lennon VA (1976) Experimental autoimmune myasthenia: clinical, neurophysiologic, and pharmacologic aspects. Ann NY Acad Sci 274: 275

    PubMed  Google Scholar 

  169. Seybold ME, Baergen RN, Nave B (1978) Anti-acetylcholine receptor antibody concentrations after thymectomy in patients with myasthenia gravis. Br Med J 2: 1051

    PubMed  Google Scholar 

  170. Seybold ME, Lindstrom JM (1979) Serial anti-acetylcholine receptor antibody titers in patients with myasthenia gravis: effects of steroid therapy. In: Dan PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 307

    Google Scholar 

  171. Seybold ME, Lindstrom JM (1981) Myasthenia gravis in infancy. Neurology (NY) 31: 476

    Google Scholar 

  172. Seybold ME, Lindstrom JM (1981) Patterns of acetylcholine receptor antibody fluctuation in myasthenia gravis. Ann NY Acad Sci 377: 292

    PubMed  Google Scholar 

  173. Seybold M, Tsoukas C, Lindstrom J (1982) Leukoplasmapheresis for myasthenia gravis. Arch Neurol 39: 433

    PubMed  Google Scholar 

  174. Shore A, Limatibul S, Dosch H-M (1979) Identification of two serum components regulating the expression of T-lymphocyte function in childhood myasthenia gravis. N Engl J Med 301: 625

    PubMed  Google Scholar 

  175. Simpson JA (1958) An evaluation of thymectomy in myasthenia gravis. Brain 81: 112

    PubMed  Google Scholar 

  176. Sine SM, Taylor P (1981) Relationship between reversible agonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem 256: 6692

    PubMed  Google Scholar 

  177. Sine SM, Taylor P (1982) Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor: studies in muscle cell culture. J Biol Chem 257: 8106

    PubMed  Google Scholar 

  178. Skolnik PR, Lisak REP, Zweiman B (1982) Monoclonal antibody analysis of blood T-cell subsets in myasthenia gravis. Ann Neurol 11: 170

    PubMed  Google Scholar 

  179. Stanley EF, Drachman DB (1978) Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Science 200: 1285

    PubMed  Google Scholar 

  180. Stockman GD, Heim LR, South MA (1973) Differential effects of cyclophosphamide on the B and T cell compartments of adult mice. J Immunol 110: 277

    PubMed  Google Scholar 

  181. Tarrab-Hazdai R, Aharonov A, Abramsky O (1975) Passive transfer of experimental autoimmune myasthenia by lymph node cells in inbred guinea pigs. J Exp Med 142: 785

    PubMed  Google Scholar 

  182. Tiendt TN, Albuquerque EX, Hudson CD (1978) Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology. J Pharmacol Exp Ther 205: 326

    PubMed  Google Scholar 

  183. Tindall RSA, Hudson J, Miller AE (1982) Immune regulation in myasthenia gravis: Evidence for an increased suppressor T-cell population. Ann Neurol 12: 341

    PubMed  Google Scholar 

  184. Torda C, Wolff HG (1949) Effects of adrenocorticotrophic hormone on neuro-muscular function in patients with myasthenia gravis. J Clin Invest 28: 1228

    Google Scholar 

  185. Toyka KV, Drachman DB, Pestronk A (1975) Myastbenia gravis: passive transfer from man to mouse. Science 190: 397

    PubMed  Google Scholar 

  186. Tzartos SJ, Lindstrom JM (1980) Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits. Proc Natl Acad Sci USA 77: 755

    PubMed  Google Scholar 

  187. Tzartos SJ, Rand DE, Einarson BL (1981) Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies. J Biol Chem 256: 8635

    PubMed  Google Scholar 

  188. Tzartos SJ, Seybold ME, Lindstrom JM (1982) Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci USA 79: 188

    PubMed  Google Scholar 

  189. Vincent A, Scadding GK, Thomas HC (1978) In vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1: 305

    PubMed  Google Scholar 

  190. Vincent A, Newsom-Davis J (1980) Anti-acetylcholine receptor antibodies. J Neurol Neurosurg Psychiatry 43: 590

    PubMed  Google Scholar 

  191. Walker MB (1934) Treatment of myathenia gravis with physostigmine. Lancet 1: 1200

    Google Scholar 

  192. Warmolts JR, Engel WK (1972) Benefit from alternate-day prednisone in myathenia gravis. N Eng] J Med 286: 17

    Google Scholar 

  193. Wecker L, Laskowski MB, Dettbarn W-D (1978) Neuromuscular dysfunction induced by acetylcholinesterase inhibition. Fed Proc 37: 2818

    PubMed  Google Scholar 

  194. Weill CL, McNamee MG, Karlin A (1974) Affinity-labeling of purified acetylcholine receptor fromTorpedo californica. Biochem Biophys Res Commun 61: 997

    PubMed  Google Scholar 

  195. Wekerle H, Ketelson U-P, Zurn AD (1978) Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells. Eur J Immunol 8: 579

    PubMed  Google Scholar 

  196. Wilson RW, Ward MD, Johns TR (1974) Corticosteroids: a direct effect at the neuromuscular junction. Neurology (NY) 24: 1091

    Google Scholar 

  197. Wolters ECMJ, Leeuwin RS (1976) Effect of corticosteroids on the phrenic nerve-diaphragm preparation treated with hemicholinium. A possible model of myasthenia gravis. Neurology (NY) 26: 574

    Google Scholar 

  198. Zollinger RM Jr, Linden MC Jr, Filler RM (1964) Effect of thymectomy on skin-homograft survival in children. N Engl J Med 270: 707

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. San Diego Veterans Administration Medical Center and Departments of Neurosciences and Surgery, University of California, 92161, San Diego, California, USA

    Marjorie E. Seybold

  2. Salk Institute for Biological Studies, P. O. Box 85800, 92138, San Diego, CA, USA

    Jon M. Lindstrom

Authors
  1. Marjorie E. Seybold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jon M. Lindstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seybold, M.E., Lindstrom, J.M. Immunopathology of acetylcholine receptors in myasthenia gravis. Springer Semin Immunopathol 5, 389–412 (1982). https://doi.org/10.1007/BF01857427

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857427

Keywords

Search

Navigation